Clinical Trial News and Research

RSS

Scientist receives $2.7 million DoD grant for research on veterans with chronic TBI

A researcher from the Center for BrainHealth at UT Dallas has been awarded a $2.7 million grant from the Department of Defense under the Joint Warfighter Medical Research Program.

11 Jan 2017

Drug that improves blood flow in damaged heart may be possible treatment option for TNBC

Researchers are looking at a drug once used to improve blood flow in damaged hearts in thousands of patients as a possible treatment option for triple negative breast cancer (TNBC).

6 Jan 2017

Unique type of airway inflammation could make African Americans less responsive to asthma treatment

African Americans may be less responsive to asthma treatment and more likely to die from the condition, in part, because they have a unique type of airway inflammation, according to a study led by researchers at the University of Illinois at Chicago College of Medicine.

6 Jan 2017

Houston Methodist researchers advance potential treatment for metaplastic breast cancer

Houston Methodist Hospital researchers have advanced a potential treatment for metaplastic breast cancer--the most aggressive subtype of triple negative breast cancer, into patients in just under four years.

6 Jan 2017

Study shows promising results for treating lymphoma patients with immune cell therapy

Lymphoma is the most common blood cancer. The disease occurs when immune cells called lymphocytes multiply uncontrollably. Cancerous lymphocytes can travel throughout the body and form lymph node tumors.

6 Jan 2017

FDA-approved, bioengineered living-cell therapy can shift genomic profile of non-healing wounds

Apligraf - an FDA-approved, bioengineered living-cell therapy from Organogenesis Inc. - has become the first wound-healing therapy to demonstrate a significant change in the genomic profile of a treated non-healing wound, according to new research published in the peer-reviewed journal Science Translational Medicine.

6 Jan 2017

Monthly high dose of vitamin D lowers respiratory infections in older adults

In people over the age of 65, acute respiratory infections--such as the common cold, influenza, or pneumonia--can lead to potentially life-threatening complications.

5 Jan 2017

Experts issue clinical guidelines to help early introduction of peanut-containing foods to infants

An expert panel sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, issued clinical guidelines today to aid health care providers in early introduction of peanut-containing foods to infants to prevent the development of peanut allergy.

5 Jan 2017

New research suggests novel combination approach to fight against gliomas

"Devastating" and "dismal." That's how leading researchers describe the present outlook for malignant brain tumors. The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months.

4 Jan 2017

CRCHUM receives NIH grant to study ways to prevent mortality after myocardial infarction

The University of Montreal Hospital Research Centre has been awarded a grant of US$2 million from the National Institutes of Health to pilot the Canadian component of a study to determine the optimal amount of blood to transfuse in anemic patients who have suffered a myocardial infarction.

4 Jan 2017

HER2-targeted dendritic cell vaccine shows promise for treating early-stage breast cancer patients

Deregulation and inhibition of the immune system contributes to cancer development. Many therapeutic strategies aim to restimulate the immune system to recognize cancer cells and target them for destruction.

3 Jan 2017

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Ardelyx, Inc., a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases, today announced the initiation of a Phase 3 clinical trial and an onset-of-action clinical trial evaluating RDX7675 in patients with hyperkalemia, a potentially life-threatening condition common in patients with cardiorenal disease.

3 Jan 2017

Columbia University Medical Center to evaluate Biocept's Target Selector platform to diagnose LM in breast cancer patients

Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selector™ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer.

30 Dec 2016

Scripps physician first to treat heart attack patients with supersaturated oxygen therapy

A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) system in an attempt to reduce permanent damage to their heart muscle.

30 Dec 2016

New molecular imaging technologies can make it easier to treat cancers, minimize side effects

New molecular imaging technologies can make it easier to diagnose, monitor, and treat cancers while potentially saving patients from undergoing therapies that are likely to be ineffective and playing a role in minimizing side effects, according to experts from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania.

30 Dec 2016

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.

29 Dec 2016

Clinical Trial News and Research

Scientist receives $2.7 million DoD grant for research on veterans with chronic TBI

Drug that improves blood flow in damaged heart may be possible treatment option for TNBC

Unique type of airway inflammation could make African Americans less responsive to asthma treatment

Houston Methodist researchers advance potential treatment for metaplastic breast cancer

Study shows promising results for treating lymphoma patients with immune cell therapy

FDA-approved, bioengineered living-cell therapy can shift genomic profile of non-healing wounds

Monthly high dose of vitamin D lowers respiratory infections in older adults

Experts issue clinical guidelines to help early introduction of peanut-containing foods to infants

New research suggests novel combination approach to fight against gliomas

CRCHUM receives NIH grant to study ways to prevent mortality after myocardial infarction

HER2-targeted dendritic cell vaccine shows promise for treating early-stage breast cancer patients

Ardelyx initiates two clinical trials to evaluate new treatment for hyperkalemia

Columbia University Medical Center to evaluate Biocept's Target Selector platform to diagnose LM in breast cancer patients

Scripps physician first to treat heart attack patients with supersaturated oxygen therapy

New molecular imaging technologies can make it easier to treat cancers, minimize side effects

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

Kessler Foundation researcher receives grant to identify treatments for cognitive deficits in people with SCI

Reduced radiation can maintain high cure rates in patients with HPV-related oropharyngeal cancers

CSHL researcher-inventor hails FDA approval of new SMA drug

New study shows efficacy of Ebola vaccine in offering protection against disease

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer